Gerald M. Ostrov - Jan 1, 2022 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-Fact
Stock symbol
ENTX
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
4
Date filed
1/13/2022, 03:03 PM
Next filing
Jan 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTX Stock Option (right to buy) Award $0 +35.9K $0.00 35.9K Jan 1, 2022 Ordinary Shares, par value NIS 0.0000769 per share 35.9K $2.82 Direct F1
transaction ENTX Stock Option (right to buy) Award $0 +108K $0.00 108K Jan 1, 2022 Ordinary Shares, par value NIS 0.0000769 per share 108K $2.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2022.
F2 The options vest ratably on a quarterly basis over a three-year period that commenced on January 1, 2022.